» Authors » Allan Levey

Allan Levey

Explore the profile of Allan Levey including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 1832
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Borgne J, Gomez L, Heikkinen S, Amin N, Ahmad S, Choi S, et al.
Mol Psychiatry . 2024 Dec; PMID: 39633006
Due to methodological reasons, the X-chromosome has not been featured in the major genome-wide association studies on Alzheimer's Disease (AD). To address this and better characterize the genetic landscape of...
2.
Tumati S, Herrmann N, Perin J, Rosenberg P, Lerner A, Mintzer J, et al.
Int Psychogeriatr . 2024 Sep; 36(12):1232-1244. PMID: 39297292
Objectives: Among participants with Alzheimer's disease (AD) we estimated the minimal clinically important difference (MCID) in apathy symptom severity on three scales. Design: Retrospective anchor- and distribution-based analyses of change...
3.
Daniels A, McDade E, Llibre-Guerra J, Xiong C, Perrin R, Ibanez L, et al.
medRxiv . 2024 Aug; PMID: 39148846
This manuscript describes and summarizes the Dominantly Inherited Alzheimer Network Observational Study (DIAN Obs), highlighting the wealth of longitudinal data, samples, and results from this human cohort study of brain...
4.
Zeng L, Perin J, Gross A, Shade D, Lanctot K, Lerner A, et al.
Int J Geriatr Psychiatry . 2024 Jun; 39(6):e6108. PMID: 38858522
Objectives: To examine clinically important adverse events (AEs) associated with methylphenidate (MPH) treatment of apathy in Alzheimer's Disease (AD) versus placebo, including weight loss, vital signs, falls, and insomnia. Methods:...
5.
Pett L, Li Z, Abrishamcar S, Hodge K, Everson T, Christensen G, et al.
Aging (Albany NY) . 2024 Apr; 16(8):6694-6716. PMID: 38663907
Previous research has found that living in a disadvantaged neighborhood is associated with poor health outcomes. Living in disadvantaged neighborhoods may alter inflammation and immune response in the body, which...
6.
Cary G, Wiley J, Gockley J, Keegan S, Amirtha Ganesh S, Heath L, et al.
Alzheimers Dement (N Y) . 2024 Apr; 10(2):e12461. PMID: 38650747
Introduction: Alzheimer's disease (AD) is the predominant dementia globally, with heterogeneous presentation and penetrance of clinical symptoms, variable presence of mixed pathologies, potential disease subtypes, and numerous associated endophenotypes. Beyond...
7.
Ikanga J, Patrick S, Schwinne M, Patel S, Epenge E, Gikelekele G, et al.
Front Neurol . 2024 Apr; 15:1320727. PMID: 38601333
Background: The current study examined the sensitivity of two memory subtests and their corresponding learning slope metrics derived from the African Neuropsychology Battery (ANB) to detect amyloid pathology and APOEε4...
8.
Schwinne M, Alonso A, Roberts B, Hickle S, Verberk I, Epenge E, et al.
J Alzheimers Dis . 2024 Feb; 97(3):1353-1363. PMID: 38306056
Background: Alzheimer's disease (AD), the most common cause of dementia, poses a significant global burden. Diagnosis typically involves invasive and costly methods like neuroimaging or cerebrospinal fluid (CSF) biomarker testing...
9.
Gudmundsdottir V, Frick E, Emilsson V, Jonmundsson T, Steindorsdottir A, Johnson E, et al.
Res Sq . 2024 Jan; PMID: 38260284
The current demand for early intervention, prevention, and treatment of late onset Alzheimer's disease (LOAD) warrants deeper understanding of the underlying molecular processes which could contribute to biomarker and drug...
10.
Britton G, Huang L, Villarreal A, Levey A, Philippakis A, Hu C, et al.
Alzheimers Dement (Amst) . 2023 Nov; 15(4):e12495. PMID: 38034851
A rapidly aging world population is fueling a concomitant increase in Alzheimer's disease (AD) and related dementias (ADRD). Scientific inquiry, however, has largely focused on White populations in Australia, the...